Y
Youssef Oulkhouir
Researcher at University of Caen Lower Normandy
Publications - 28
Citations - 840
Youssef Oulkhouir is an academic researcher from University of Caen Lower Normandy. The author has contributed to research in topics: Medicine & Nivolumab. The author has an hindex of 7, co-authored 22 publications receiving 280 citations.
Papers
More filters
Journal ArticleDOI
First-line nivolumab plus ipilimumab in unresectable malignant pleural mesothelioma (CheckMate 743): a multicentre, randomised, open-label, phase 3 trial.
Paul Baas,Arnaud Scherpereel,Anna K. Nowak,Nobukazu Fujimoto,Solange Peters,Anne S. Tsao,Aaron S. Mansfield,Sanjay Popat,Thierry Jahan,Scott J. Antonia,Youssef Oulkhouir,Yolanda Bautista,Robin Cornelissen,Laurent Greillier,Francesco Grossi,Dariusz M. Kowalski,Jerónimo Rodríguez-Cid,Praveen Aanur,Abderrahim Oukessou,Christine Baudelet,Gérard Zalcman +20 more
TL;DR: The CheckMate 743 trial as mentioned in this paper showed that nivolumab plus ipilimumab significantly improved overall survival compared to standard-of-care chemotherapy for non-small-cell lung cancer.
Journal ArticleDOI
First-line nivolumab plus ipilimumab versus chemotherapy in patients with unresectable malignant pleural mesothelioma: 3-year outcomes from CheckMate 743.
S. Peters,Arnaud Scherpereel,Robin Cornelissen,Youssef Oulkhouir,Laurent Greillier,Muhammet Ali Kaplan,T. Talbot,Isabelle Monnet,Sandrine Hiret,Paul Baas,Anna K. Nowak,N. Fujimoto,Anne Tsao,Aaron S. Mansfield,Sanjay Popat,X. Zhang,Ning Hu,David Balli,Thomas Spires,Gérard Zalcman +19 more
TL;DR: In this article , first-line nivolumab plus ipilimumab significantly improved overall survival (OS) versus chemotherapy in patients with unresectable malignant pleural mesothelioma (MPM).
Journal ArticleDOI
Retrospective observational study of diagnostic accuracy of the Xpert® MTB/RIF assay on fiberoptic bronchoscopy sampling for early diagnosis of smear-negative or sputum-scarce patients with suspected tuberculosis
Pierre Le Palud,Vincent Cattoir,Brigitte Malbruny,Romain Magnier,K. Campbell,Youssef Oulkhouir,Gérard Zalcman,Emmanuel Bergot +7 more
TL;DR: The clinical benefits provided by XP assay compared to SM for the early diagnosis of suspected pulmonary TB cases requiring FOB, on per procedure samples, especially in a low TB-burden country is confirmed.
Journal ArticleDOI
ID:2908 First-Line Nivolumab + Ipilimumab vs Chemotherapy in Unresectable Malignant Pleural Mesothelioma: CheckMate 743
Paul Baas,Arnaud Scherpereel,Anna K. Nowak,N. Fujimoto,Solange Peters,Anne Tsao,Aaron S. Mansfield,Sanjay Popat,T. Jahan,S.J. Antonia,Youssef Oulkhouir,Y. Bautista,Robin Cornelissen,Laurent Greillier,Francesco Grossi,Dariusz M. Kowalski,Jerónimo Rodríguez-Cid,Praveen Aanur,Christine Baudelet,Gérard Zalcman +19 more
Journal ArticleDOI
Generating harmonized SUV within the EANM EARL accreditation program: software approach versus EARL-compliant reconstruction
Charline Lasnon,Thibault Salomon,Cédric Desmonts,Pascal Do,Youssef Oulkhouir,Jeannick Madelaine,Nicolas Aide,Nicolas Aide +7 more
TL;DR: The issue of reconstruction dependency in SUV values that hampers the comparison of data between different PET systems can be overcome using two reconstructions for harmonized quantification and optimal diagnosis or using the EQ.PET technology.